Pharmaceutical Processing World Archives - Page 64 of 64

ACG receives Clean Label Project certification for capsules

[Image courtesy of ACG]

ACG (Mumbai, India) announced today that the nonprofit Clean Label Project has certified its ACGcaps H+.

Clean Label Project certification signifies that a product has met strict and comprehensive testing to demonstrate a priority on purity and environmental sustainability, according to ACG. The nonprofit evaluates test results against California Proposition 65, which is meant to protect products from contaminants known to cause cancer, birth defects or other reproductive harm.

ACGcaps H+ capsules are suitable for filling granules, powders, pellets for prescription and non-prescription pharmaceutical ingredients, nutraceutical dietary supplements, and traditional medicines.

Gilead licenses remdesivir production to 5 generic drugmakers

Gilead Sciences’ (NSDQ:GILD) said Tuesday that it has signed licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand supply of remdesivir, the experimental drug being used in the U.S. to treat COVID-19.

The non-exclusive, voluntary agreements allow the companies — Mylan (NSDQ:MYL), Cipla, Ferozsons Laboratories, Hetero Labs and Jubilant Lifesciences — to manufacture remdesivir for distribution in 127 countries. The countries consist of nearly all low-income and lower-middle income countries, as well as several upper-middle- and high-income countries that face significant obstacles to healthcare access, according to Foster City, Calif.-based Gilead.

Get the full story on our sister site, MassDevice.

Pfizer to outsource more production as it prepares for COVID-19 vaccine

Pfizer is turning to its 200-strong network of outside contractors to make more of its existing medicines as it prepares for a potential COVID-19 vaccine., according to media reports.

The New York–based pharmaceutical giant said May 5 that it will invest at-risk to produce millions of doses of a coronavirus vaccine in 2020, boosting production to hundreds of millions of doses in 2021. Pfizer sites in Massachusetts, Michigan, Missouri and Puurs, Belgium will serve as vaccine manufacturing centers — with more sites expected to be added to the list.

BioNTech — Pfizers’s partner in developing a COVID-19 vaccine — plans to ramp up production sites in Mainz and Idar-Oberstein, Germany,

The first participants in Pfizer and BioNTech’s Phase 1/2 clinical trial for the BNT162 vaccine program have already been dosed in Germany and the U.S.

“The short, less than four-month timeframe in which we’ve been able to move from pre-clinical studies …

India-led research effort asks the question: How do we keep a potential COVID-19 vaccine cold?

[Image courtesy of University of Birmingham]

U.K. scientists have joined a research effort in India to help solve distribution problems around whatever COVID-19 vaccine hopefully emerges from global efforts, according to a recent news release from the University of Birmingham.

Backed by the Shakti Sustainable Energy Foundation, experts from the University of Birmingham and Heriot-Watt University, Edinburgh are investigating the challenge involved in distributing a potentially temperature-sensitive COVID–19 vaccine.

The Centre for Environment Education (CEE) in India is leading the overall research, with support from commercial partners such as Zanotti (a part of the Daikin Group), Sure Chill and Nexleaf Analytics. The British researchers are exploring how integrated “Community Cooling Hubs’” can integrate food cold chains with other cold-dependent services such as community health fac…